EPISODE · Jun 5, 2026 · 18 MIN
Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances Emerge
from PeerVoice Clinical Pharmacology Video · host PeerVoice
Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances Emerge
Embed this episode
What this episode covers
For the complete activity, including supporting material, please visit https://www.peervoice.com/TPE860. Presented by Silvia Stacchiotti, MD and Michiel van de Sande, MD, PhD. Learning Objectives: Describe the clinical evidence supporting emerging systemic therapies for tenosynovial giant cell tumour (TGCT); Identify factors that influence decisions on whether to opt for systemic treatment versus surgical intervention; Analyse case scenarios to propose evidence-based treatment plans for patients with TGCT.
Ready to play
Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances Emerge
No transcript for this episode yet
Similar Episodes
No similar episodes found.